[Federal Register Volume 78, Number 72 (Monday, April 15, 2013)]
[Notices]
[Pages 22267-22268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-08730]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-13-0457]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-7570 or 
send comments to Ron Otten, 1600 Clifton Road, MS-D74, Atlanta, GA 
30333 or send an email to [email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Aggregate Reports for Tuberculosis Program Evaluation (0920-0457--
Exp. 9-30-2013)--Extension--National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    CDC requests the extension of the Aggregate Reports for 
Tuberculosis Program Evaluation, previously approved under OMB No. 
0920-0457 for 3-years. There are no revisions to the report forms, data 
definitions, or reporting instructions.
    To ensure the elimination of tuberculosis in the United States, CDC 
monitors indicators for key program activities, such as finding 
tuberculosis infections in recent contacts of cases and in other 
persons likely to be infected and providing therapy for latent 
tuberculosis infection. In 2000, CDC implemented two program evaluation 
reports for annual submission: Aggregate report of follow-up for 
contacts of tuberculosis, and Aggregate report of screening and 
preventive therapy for tuberculosis infection (OMB No. 0920-0457). The 
respondents for these reports are the 68 state and local tuberculosis 
control programs receiving federal cooperative agreement funding 
through the CDC Division of Tuberculosis Elimination (DTBE). These 
reports emphasize treatment outcomes, high-priority target populations 
vulnerable to tuberculosis,

[[Page 22268]]

and programmed electronic report entry, which transitioned to the 
National Tuberculosis Indicators Project (NTIP), a secure web-based 
system for program evaluation data, in 2010. No other federal agency 
collects this type of national tuberculosis data, and the Aggregate 
report of follow-up for contacts of tuberculosis, and Aggregate report 
of screening and preventive therapy for tuberculosis infection are the 
only data source about latent tuberculosis infection for monitoring 
national progress toward tuberculosis elimination with these 
activities. CDC provides ongoing assistance in the preparation and 
utilization of these reports at the local and state levels of public 
health jurisdiction. CDC also provides respondents with technical 
support for the NTIP software (Electronic--100%, Use of Electronic 
Signatures--No).
    There is no cost to respondents.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                          Number of      Average burden   Total
       Type of respondent             Form name         Number of       responses per     per response    burden
                                                       respondents       respondent        (in hours)     hours
----------------------------------------------------------------------------------------------------------------
Data clerks and Program          Follow-up and                  100  1 (electronic)....           30/60       50
 Managers.                        Treatment of
                                  Contacts to
                                  Tuberculosis
                                  Cases Form.
Program Mangers................  Follow-up and                   18  1 (manual)........           30/60        9
                                  Treatment of
                                  Contacts to
                                  Tuberculosis
                                  Cases Form.
Data clerks....................  Follow-up and                   18  1 (manual)........               3       54
                                  Treatment of
                                  Contacts to
                                  Tuberculosis
                                  Cases Form.
Data clerks and Program          Targeted Testing               100  1 (electronic)....           30/60       50
 Managers.                        and Treatment for
                                  Latent
                                  Tuberculosis
                                  Infection.
Program Mangers................  Targeted Testing                18  1 (manual)........           30/60        9
                                  and Treatment for
                                  Latent
                                  Tuberculosis
                                  Infection.
Data clerks....................  Targeted Testing                18  1 (manual)........               3       54
                                  and Treatment for
                                  Latent
                                  Tuberculosis
                                  Infection.
                                --------------------------------------------------------------------------------
    Total......................  ..................  ..............  ..................  ..............      226
----------------------------------------------------------------------------------------------------------------


Ron A. Otten,
Director, Office of Scientific Integrity, Office of the Associate 
Director for Science, Office of the Director, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-08730 Filed 4-12-13; 8:45 am]
BILLING CODE 4163-18-P